Midodrin Evolan (Midodrine Hydrochloride)

Midodrine Hydrochloride, the active ingredient in Midodrin Evolan, is a Alpha-1 adrenergic agonist presented as an oral tablet for oral use. It treats orthostatic hypotension in adults by raising standing blood pressure and reducing dizziness or fainting episodes.

GNH USA supplies Midodrin Evolan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Midodrine Hydrochloride is used to manage conditions related to low blood pressure by activating peripheral alpha‑1 adrenergic receptors.

- Orthostatic hypotension: Increases standing blood pressure and reduces symptoms such as dizziness, light‑headedness, or syncope.

Midodrine Hydrochloride may cause a range of adverse reactions. Most are mild and reversible.

Common Side Effects: - Headache: mild to moderate pressure sensation. - Supine hypertension: elevated blood pressure when lying down. - Piloerection: localized goose‑flesh skin reaction. - Nausea: occasional stomach upset.

Serious or Rare Side Effects: - Severe hypertension: rapid, high rise in blood pressure requiring medical attention. - Bradycardia: unusually slow heart rate. - Myocardial ischemia: chest pain or heart attack symptoms. - Allergic reactions: rash, itching, or swelling. - Angioedema: swelling of face, lips, or throat.

Before prescribing Midodrine Hydrochloride, clinicians should consider several safety measures.

- Dose titration: adjust based on individual blood pressure response. - Supine hypertension monitoring: avoid lying flat soon after dosing. - Renal impairment: use with caution in patients with reduced kidney function. - Cardiovascular disease: assess risk of excessive pressor effect. - Store at ambient temperature: keep in the original pack, protect from moisture.

Midodrine Hydrochloride can interact with other agents that affect blood pressure or sympathetic activity.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: additive pressor effect. - Sympathomimetic agents: excessive hypertension.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive effect. - Beta‑blockers: may blunt compensatory tachycardia. - ACE inhibitors: possible variability in blood pressure control.